|
|
|
Please share your messages, questions, concerns, or ideas. >
Indomethacin (CAS 53-86-1): A Scientific and Clini
Indomethacin (CAS 53-86-1): A Scientific and Clini
Page:
1
Guest
Guest
Feb 09, 2026
12:50 AM
|
Indomethacin, chemically designated as 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid (CAS 53-86-1), stands as a historically significant and clinically indispensable nonsteroidal anti-inflammatory drug (NSAID). With a well-characterized mechanism of action targeting prostaglandin biosynthesis, indomethacin occupies a central role in anti-inflammatory therapy and other specialized clinical indications. Its robust pharmacodynamic effects, broad therapeutic applications, and well-documented safety profile make it a staple in both human and specialized veterinary medicine — and a strategic active pharmaceutical ingredient (API) offering for Alfa Chemistry’s pharmaceutical partners.
Chemical and Physicochemical Profile
Indomethacin's molecular formula C19H16ClNO4 and molecular weight, 357.79 g/mol, reflect its moderately complex indole-acetic acid structure, amenable to diverse formulation strategies. In its typical API form, indomethacin appears as a white to pale yellow crystalline powder with limited water solubility and greater solubility in organic solvents—a characteristic guiding both formulation and processing decisions in pharmaceutical manufacturing.
From a chemical stability perspective, indomethacin is stable in neutral to slightly acidic environments but degrades in strong alkaline conditions, with a pKa around 4.5. These properties underscore the importance of pH control in formulation and delivery systems to maintain pharmaceutical integrity and bioavailability.
Mechanism of Action: Biochemical and Pharmacological Insights
As a non-selective cyclooxygenase (COX) inhibitor, indomethacin reduces the synthesis of prostaglandins—lipid mediators that sensitize nociceptors and regulate inflammation, pain, and fever. By competitively inhibiting COX-1 and COX-2 isoenzymes, it disrupts the prostaglandin biosynthetic pathway, leading to well-documented analgesic, anti-inflammatory, and antipyretic effects.
While structural modifications and derivative research aim to enhance selectivity or reduce side effects, the core API remains a potent agent for modulating inflammatory processes. Emerging research has even explored indomethacin's influence on cellular pathways beyond COX inhibition—including effects on leukocyte function and reactive oxygen species—though such mechanisms are context-dependent and an area of ongoing scientific inquiry.
Clinical Applications and Therapeutic Utility
A. Rheumatologic and Musculoskeletal Disorders
Indomethacin continues to be prescribed for a variety of moderate to severe inflammatory conditions, including:
Rheumatoid Arthritis—attenuating inflammatory flares and joint pain, especially when other NSAIDs are insufficient.
Ankylosing Spondylitis—managing spinal stiffness and inflammation characteristic of this chronic spondyloarthropathy.
Osteoarthritis—offering symptomatic relief where inflammation contributes to pain and mobility impairment.
Acute Gout Flares—achieving rapid reduction in painful inflammation during early gout attacks.
These indications highlight indomethacin's ongoing relevance in inflammatory disease management when tailored to appropriate patient populations.
B. Patent Ductus Arteriosus (PDA) in Neonatology
Beyond its conventional analgesic role, indomethacin plays a critical role in neonatal medicine. The intravenous formulation is used to induce closure of hemodynamically significant patent ductus arteriosus in preterm infants—a life-threatening congenital condition that can compromise cardiac and pulmonary function.
C. Adjunct and Off-Label Uses
While not primary therapeutic indications, indomethacin has been studied or deployed off-label for other conditions, such as:
Headache syndromes and dysmenorrhea
Certain inflammatory dermatologic conditions
Investigative oncology models (e.g., effects on cell apoptosis pathways)
These uses reflect the compound's versatility, though they should be grounded in evidence-based practice and regulatory guidance.
API Synthesis and Manufacturing Considerations
The classical synthetic route to indomethacin typically proceeds via a Fischer indole synthesis, combining 4-methoxyphenylhydrazine with levulinic acid derivatives, followed by selective acylation and acid hydrolysis to yield the 1-(4-chlorobenzoyl) indole core. While this multistep pathway is robust and well-validated, modern methodologies—including palladium-catalyzed C–H functionalization routes—have demonstrated streamlined synthesis with improved yields and regioselectivity.
From a process development perspective, yield optimization and impurity profiling remain central to delivering a high-quality API that meets pharmacopeial standards. Alfa Chemistry's manufacturing expertise ensures rigorous control over these parameters, supporting consistent supply for both clinical and commercial APIs.
Safety, Tolerability, and Risk Management
NSAIDs as a class share a characteristic safety profile, and indomethacin's non-selectivity for COX-1 contributes to both therapeutic efficacy and adverse events. Of note:
Gastrointestinal toxicity—including dyspepsia, ulceration, and bleeding—is a key concern due to COX-1 inhibition reducing protective prostaglandins in the gastric mucosa.
Central nervous system effects—such as headache, dizziness, and rarely confusion—occur more frequently with indomethacin compared to some other NSAIDs.
Renal and cardiovascular considerations—including fluid retention, hypertension, and risk of cardiac events, particularly with long-term use.
Hypersensitivity and dermatologic reactions—ranging from urticaria to rare severe cutaneous adverse reactions.
Appropriate risk mitigation—such as dosing strategies, concomitant gastric protection, and careful patient selection—is critical in clinical use. From an API standpoint, maintaining high purity and consistency directly impacts both efficacy and safety outcomes in finished dosage forms.
Conclusion
Indomethacin exemplifies a mature but continually relevant pharmaceutical API. Its well-understood mechanisms of action, broad spectrum of therapeutic indications, and established manufacturing pathways underscore its enduring value in drug development and patient care. Alfa Chemistry's commitment to scientific excellence and stringent quality standards positions its indomethacin API as a dependable choice for pharmaceutical innovators worldwide.
|
Post a Message
|
|